Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Lespek Kutumbetov"'
Autor:
Zhandos Abay, Sandugash Sadikaliyeva, Ainur Nurpeisova, Kuanysh Jekebekov, Kamshat Shorayeva, Bolat Yespembetov, Sergazy Nurabayev, Aslan Kerimbayev, Berik Khairullin, Hansang Yoo, Lespek Kutumbetov, Markhabat Kassenov, Kunsulu Zakarya
Publikováno v:
Viruses, Vol 16, Iss 6, p 956 (2024)
The emergence of the novel coronavirus SARS-CoV-2 has led to significant interest in its potential transmission between animals and humans, especially pets. This review article summarises the literature on coronavirus infections in domestic animals,
Externí odkaz:
https://doaj.org/article/611d686fd1a94453a800b0f6b59fea81
Autor:
Kamshat Shorayeva, Aziz Nakhanov, Ainur Nurpeisova, Olga Chervyakova, Kuanysh Jekebekov, Zhandos Abay, Nurika Assanzhanova, Sandugash Sadikaliyeva, Elina Kalimolda, Aibol Terebay, Sabina Moldagulova, Zharkinay Absatova, Ali Tulendibayev, Syrym Kopeyev, Gulnur Nakhanova, Aisha Issabek, Sergazy Nurabayev, Aslan Kerimbayev, Lespek Kutumbetov, Yergali Abduraimov, Markhabat Kassenov, Mukhit Orynbayev, Kunsulu Zakarya
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1771 (2023)
Creating an effective and safe vaccine is critical to fighting the coronavirus infection successfully. Several types of COVID-19 vaccines exist, including inactivated, live attenuated, recombinant, synthetic peptide, virus-like particle-based, DNA an
Externí odkaz:
https://doaj.org/article/61ec8e64110c4ec2aa11e3303deeeed9
Autor:
Ainur Nurpeisova, Berik Khairullin, Ruslan Abitaev, Kamshat Shorayeva, Kuanish Jekebekov, Elina Kalimolda, Aslan Kerimbayev, Karligash Akylbayeva, Zhandos Abay, Balzhan Myrzakhmetova, Aziz Nakhanov, Zharkinay Absatova, Sergazy Nurabayev, Mukhit Orynbayev, Nurika Assanzhanova, Khairulla Abeuov, Lespek Kutumbetov, Markhabat Kassenov, Yergaly Abduraimov, Kunsulu Zakarya
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
This article describes the results of a preclinical safety and immunogenicity study of QazCovid-in®, the first COVID-19 vaccine developed in Kazakhstan, on BALB/c mice, rats, ferrets, Syrian hamsters and rhesus macaques (Macaca mulatta). The study
Externí odkaz:
https://doaj.org/article/5ad1a52732d14c0ab5fbc7000b284a8c
Autor:
Berik Khairullin, Kunsulu Zakarya, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Gulbanu Sarsenbayeva, Kulyaisan Sultankulova, Olga Chervyakova, Balzhan Myrzakhmetova, Aziz Nakhanov, Ainur Nurpeisova, Kuandyk Zhugunissov, Nurika Assanzhanova, Sergazy Nurabayev, Aslan Kerimbayev, Zakir Yershebulov, Yerbol Burashev, Ilyas Kulmagambetov, Timur Davlyatshin, Maria Sergeeva, Zhanna Buzitskaya, Marina Stukova, Lespek Kutumbetov
Publikováno v:
EClinicalMedicine, Vol 50, Iss , Pp 101526- (2022)
Summary: Background: Vaccination remains the primary measure to prevent the spread of the SARS-CoV-2 virus, further necessitating the use of effective licensed vaccines. Methods: From Dec 25, 2020, to July 11, 2021, we conducted a multicenter, random
Externí odkaz:
https://doaj.org/article/d50775b3823546d192881db931e905e3
Autor:
Kunsulu Zakarya, Lespek Kutumbetov, Mukhit Orynbayev, Yergali Abduraimov, Kulyaisan Sultankulova, Markhabat Kassenov, Gulbanu Sarsenbayeva, Ilyas Kulmagambetov, Timur Davlyatshin, Maria Sergeeva, Marina Stukova, Berik Khairullin
Publikováno v:
EClinicalMedicine, Vol 39, Iss , Pp 101078- (2021)
Background: A new inactivated whole-virion QazCovid-in® vaccine against COVID-19 was developed from SARS-CoV-2 isolated in Kazakhstan, inactivated by formaldehyde, and adjuvanted with aluminium hydroxide. Phase 1 and 2 clinical trials aimed at asses
Externí odkaz:
https://doaj.org/article/e6c3add44a0f4793996755ca1d459f79
Autor:
Kuandyk Zhugunissov, Kunsulu Zakarya, Berik Khairullin, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Kulyaisan Sultankulova, Aslan Kerimbayev, Sergazy Nurabayev, Balzhan Myrzakhmetova, Aziz Nakhanov, Ainur Nurpeisova, Olga Chervyakova, Nurika Assanzhanova, Yerbol Burashev, Muratbay Mambetaliyev, Moldir Azanbekova, Syrym Kopeyev, Nurlan Kozhabergenov, Aisha Issabek, Moldir Tuyskanova, Lespek Kutumbetov
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
In March 2020, the first cases of the human coronavirus disease COVID-19 were registered in Kazakhstan. We isolated the SARS-CoV-2 virus from clinical materials from some of these patients. Subsequently, a whole virion inactivated candidate vaccine,
Externí odkaz:
https://doaj.org/article/e6566ebc4b064a139619de8c493998fe
Autor:
Arman Issimov, David B Taylor, Malik Shalmenov, Birzhan Nurgaliyev, Izimgali Zhubantayev, Nurzhan Abekeshev, Kaissar Kushaliyev, Abzal Kereyev, Lespek Kutumbetov, Assylbek Zhanabayev, Yasmin Zhakiyanova, Peter J White
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0238210 (2021)
Lumpy skin disease (LSD) is an emerging disease of cattle in Kazakhstan and the means of transmission remains uncertain. In the current study, retention of Lumpy Skin Disease Virus (LSDV) by three Stomoxys species following intrathoracic inoculation
Externí odkaz:
https://doaj.org/article/2d73cef30ed54c4cb883f45d7370f578
Autor:
Arman Issimov, David B Taylor, Kuandyk Zhugunissov, Lespek Kutumbetov, Assylbek Zhanabayev, Nurlybay Kazhgaliyev, Aliya Akhmetaliyeva, Birzhan Nurgaliyev, Malik Shalmenov, Gaisa Absatirov, Laura Dushayeva, Peter J White
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0242794 (2020)
In this study, Stomoxys species (S. calcitrans, S. sitiens and S. indica) were examined to improve on the current technique for mass rearing using a method of combined incubation parameters. Moreover, the reproductive potential of immature forms at v
Externí odkaz:
https://doaj.org/article/a1927b2b6f0e4edf807a49bcf8c98c82
Autor:
Arman Issimov, Lespek Kutumbetov, Mukhit B. Orynbayev, Berik Khairullin, Balzhan Myrzakhmetova, Kulyaisan Sultankulova, Peter J. White
Publikováno v:
Animals, Vol 10, Iss 3, p 477 (2020)
Samples collected for PCR from recipient animals tested positive in 5 out of 6 cases, while the virus was isolated from 4 of 6 animals. The clinical signs exhibited by recipient animals were mostly moderate in nature with only one severe case. To our
Externí odkaz:
https://doaj.org/article/334b8d5927f143d5be90faefc77ac058
Autor:
Moldir TUYSKANOVA, Kuandyk ZHUGUNISSOV, Mehmet OZASLAN, Aziz NAKHANOV, Kunsulu ZAKARYA, Moldir AZANBEKOVA, Marzhan KENZHEBAEVA, Alisher OMURTAY, Arailym DZHAPASHEVA, Muratbay MAMBETALIYEV, Shalkar TABYS, Balzhan MYRZAKHMETOVA, Lespek KUTUMBETOV
Publikováno v:
The Eurasia Proceedings of Health, Environment and Life Sciences. 5:40-47
In early December 2019, humanity faced a new problem caused by a coronavirus. An epidemic event capable of causing severe primary viral pneumonia in humans began to develop in the central Chinese province of Hubei. The isolated etiological agent was